1 |
Costantini, C., Scrable, H., and Puglielli, L. (2006). An aging pathway controls the TrkA to p75NTR receptor switch and amyloid beta-peptide generation. EMBO J.25, 1997-2006
DOI
ScienceOn
|
2 |
Cowley, S., Paterson, H., Kemp, P., and Marshall, C.J. (1994). Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77, 841-852
DOI
ScienceOn
|
3 |
Kurz, E.U., and Lees-Miller, S.P. (2004). DNA damage-induced activation of ATM and ATM-dependent signaling pathways. DNA Repair 3, 889-900
DOI
ScienceOn
|
4 |
Marshall, C.J. (1995). Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80, 179-185
DOI
ScienceOn
|
5 |
Rong, J., McGuire, J.R., Fang, Z.H., Sheng, G., Shin, J.Y., Li, S.H., and Li, X.J. (2006). Regulation of intracellular trafficking of huntingtin- associated protein-1 is critical for TrkA protein levels and neurite outgrowth. J. Neurosci. 26, 6019-6030
DOI
ScienceOn
|
6 |
Shikata, A., Shikata, T., Sotozono, Y., Hosoi, H., Matsumura, T., Sugimoto, T., and Sawada, T. (2000). Neuronal differentiation in human neuroblastoma cells by nerve growth factor following TrkA up-regulation by interferon-gamma. Med. Pediatr. Oncol. 34, 394-401
DOI
ScienceOn
|
7 |
Shim, H.Y., Park, J.H., Paik, H.D., Nah, S.Y., Kim, D.S., and Han, Y.S. (2007). Acacetin-induced apoptosis of human breast cancer MCF-7 cells involves caspase cascade, mitochondriamediated death signaling and SAPK/JNK1/2-c-Jun activation. Mol. Cells 24, 95-104
|
8 |
Stephens, R.M., Loeb, D.M., Copeland, T.D., Pawson, T., Greene, L.A., and Kaplan, D.R. (1994). Trk receptors use redundant signal transduction pathways involving SHC and PLC-gamma 1 to mediate NGF responses. Neuron 12, 691-705
DOI
ScienceOn
|
9 |
Chou, T.T., Trojanowski, J.Q., and Lee, V.M. (2000). A novel apoptotic pathway induced by nerve growth factor-mediated TrkA activation in medulloblastoma. J. Biol. Chem. 275, 565-570
DOI
|
10 |
Cartron, P.F., Oliver, L., Juin, P., Meflah, K., and Vallette, F.M. (2004). The p18 truncated form of Bax behaves like a Bcl-2 homology domain 3-only protein. J. Biol. Chem. 279, 11503- 11512
DOI
ScienceOn
|
11 |
Woessmann, W., Chen, X., and Borkhardt, A. (2002). Rasmediated activation of ERK by cisplatin induces cell death independently of p53 in osteosarcoma and neuroblastoma cell lines. Cancer Chemother. Pharmacol.50, 397-404
DOI
|
12 |
Klein, R., Jing, S.Q., Nanduri, V., O'Rourke, E., and Barbacid, M. (1991). The trk proto-oncogene encodes a receptor for nerve growth factor. Cell 65, 189-197
DOI
ScienceOn
|
13 |
Friedman, W.J., and Greene, L.A. (1999). Neurotrophin signaling via Trks and p75. Exp. Cell. Res.253, 131-142
DOI
ScienceOn
|
14 |
Toyota, H., Yanase, N., Yoshimoto, T., Moriyama, M., Sudo, T., and Mizuguchi, J. (2003). Calpain-induced Bax-cleavage product is a more potent inducer of apoptotic cell death than wild-type Bax. Cancer Lett.189, 221-230
DOI
ScienceOn
|
15 |
Kurz, E.U., Douglas, P., and Lees-Miller, S.P. (2004). Doxorubicin activates ATM-dependent phosphorylation of multiple downstream targets in part through the generation of reactive oxygen species. J. Biol. Chem. 279, 53272-53281
DOI
ScienceOn
|
16 |
Reichardt, L.F. (2006). Neurotrophin-regulated signalling pathways. Phil. Trans. R. Soc. B. 361, 1545-1564
DOI
ScienceOn
|
17 |
Wood, D.E., Thomas, A., Devi, L.A., Berman, Y., Beavis, R.C., Reed, J.C., and Newcomb, E.W. (1998). Bax cleavage is mediated by calpain during drug-induced apoptosis. Oncogene 17, 1069-1078
DOI
|
18 |
Yan, C., Liang, Y., Nylander, K.D., and Schor, N.F. (2002). TrkA as a life and death receptor: receptor dose as a mediator of function. Cancer Res.62, 4867-4875
|
19 |
Schramm, A., Schulte, J.H., Astrahantseff, K., Apostolov, O., Limpt, V., Sieverts, H., Kuhfittig-Kulle, S., Pfeiffer, P., Versteeg, R., and Eggert, A. (2005). Biological effects of TrkA and TrkB receptor signaling in neuroblastoma. Cancer Lett. 228, 143-153
DOI
ScienceOn
|
20 |
Tacconelli, A., Farina, A.R., Cappabianca, L., Desantis, G., Tessitore, A., Vetuschi, A., Sferra, R., Rucci, N., Argenti, B., Screpanti, I., et al. (2004). TrkA alternative splicing: a regulated tumor-promoting switch in human neuroblastoma. Cancer Cell 6, 347-360
DOI
ScienceOn
|
21 |
Urra, S., Escudero, C.A., Ramos, P., Lisbona, F., Allende, E., Covarrubias, P., Parraguez, J.I., Zampieri, N., Chao, M.V., Annaert, W., et al. (2007). TrkA receptor activation by nerve growth factor induces shedding of the p75 neurotrophin receptor followed by endosomal gamma-secretase-mediated release of the p75 intracellular domain. J. Biol. Chem.282, 7606-7615
DOI
ScienceOn
|
22 |
Jung, E.J., and Flemington, E.K. (2001). Transfection-mediated cell synchronization: acceleration of G1-S phase transition by gamma irradiation. BioTechniques 31, 1026, 1028, 1031-1024
|
23 |
Muragaki, Y., Chou, T.T., Kaplan, D.R., Trojanowski, J.Q., and Lee, V.M. (1997). Nerve growth factor induces apoptosis in human medulloblastoma cell lines that express TrkA receptors. J. Neurosci. 17, 530-542
DOI
|
24 |
Tang, D., Wu, D., Hirao, A., Lahti, J.M., Liu, L., Mazza, B., Kidd, V.J., Mak, T.W., and Ingram, A.J. (2002). ERK activation mediates cell cycle arrest and apoptosis after DNA damage independently of p53. J. Biol. Chem.277, 12710-12717
DOI
ScienceOn
|